Ara
Toplam kayıt 1, listelenen: 1-1
Dramatic response to catumaxomab treatment for malign ascites related to renal cell carcinoma with sarcomotoid differentiation.
(Lippincott, Williams & Wilkins, 2014)
Refractory malignant ascites (MA) is a common complication in cancer patients. Renal cell carcinoma
(RCC) is rarely present with peritoneal ascites, which is commonly associated with carcinomas of the
gastrointestinal ...